Page last updated: 2024-10-31

midazolam and Shock, Cardiogenic

midazolam has been researched along with Shock, Cardiogenic in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Scherer, C1
Kleeberger, J1
Kellnar, A1
Binzenhöfer, L1
Lüsebrink, E1
Stocker, TJ1
Berghoff, SA1
Keutner, A1
Thienel, M1
Deseive, S1
Stark, K1
Braun, D1
Orban, M2
Petzold, T1
Brunner, S1
Hagl, C1
Hausleiter, J1
Massberg, S1
Endo, M1
Hirano, R1
Shibasaki, H1
Yokokawa, A1
Furuta, T1
Abe, K1
Morita, K1
Tanaka, S1
Hirano, T1
Sakurai, M1
Mizuno, K1

Other Studies

2 other studies available for midazolam and Shock, Cardiogenic

ArticleYear
Propofol versus midazolam sedation in patients with cardiogenic shock - an observational propensity-matched study.
    Journal of critical care, 2022, Volume: 71

    Topics: Conscious Sedation; Humans; Hypnotics and Sedatives; Midazolam; Propofol; Respiration, Artificial; R

2022
Midazolam Intoxication in a Premature Neonate.
    Clinical therapeutics, 2020, Volume: 42, Issue:5

    Topics: Cytochrome P-450 CYP3A; Exome Sequencing; Humans; Hydrocortisone; Hydroxylation; Hypnotics and Sedat

2020